The PE Ratio as of December 2024 (TTM) for Champions Oncology, Inc. (CSBR) is -167.15

According to Champions Oncology, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -167.15. This represents a change of 420.84% compared to the average of -32.09 of the last 4 quarters.

Champions Oncology, Inc. (CSBR) Historical PE Ratio (quarterly & annually)

How has CSBR PE Ratio performed in the past?

The mean historical PE Ratio of Champions Oncology, Inc. over the last ten years is 126.74. The current -167.15 PE Ratio has changed -13288.49% with respect to the historical average. Over the past ten years (40 quarters), CSBR's PE Ratio was at its highest in in the October 2020 quarter at 28.68K. The PE Ratio was at its lowest in in the October 2022 quarter at -1467.01.

Champions Oncology, Inc. (CSBR) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Champions Oncology, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Champions Oncology, Inc. (CSBR) Average PE Ratio

How has CSBR PE Ratio performed in the past?

The current PE Ratio of Champions Oncology, Inc. (CSBR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Champions Oncology, Inc. (CSBR) PE Ratio vs. Peers

How is CSBR’s PE Ratio compared to its peers?

Champions Oncology, Inc.’s PE Ratio is less than Molecular Partners AG (-2.46), less than MediciNova, Inc. (-0.03), less than Anebulo Pharmaceuticals, Inc. (-3.86), less than Cyteir Therapeutics, Inc. (-9.12), less than Pardes Biosciences, Inc. (-1.36), less than Shattuck Labs, Inc. (-0.76), less than Eliem Therapeutics, Inc. (0), less than Century Therapeutics, Inc. (-0.65), less than Aerovate Therapeutics, Inc. (-0.88), less than Adagene Inc. (-2.61), less than Acrivon Therapeutics, Inc. Common Stock (-3.05), less than Rezolute, Inc. (-4.45), less than AN2 Therapeutics, Inc. (-0.67), less than HCW Biologics Inc. (-0.41),

Build a custom stock screener for Champions Oncology, Inc. (CSBR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Champions Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Champions Oncology, Inc. (CSBR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Champions Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.